| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 7e-06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |